• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients

tetano

Editor, Senior Moderator
Viruses


. 2020 Sep 18;12(9):E1045.
doi: 10.3390/v12091045.
RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients


Kirsten Alexandra Eberhardt[SUP] 1 [/SUP], Charlotte Meyer-Schwickerath[SUP] 2 [/SUP], Eva Heger[SUP] 3 [/SUP], Elena Knops[SUP] 3 [/SUP], Clara Lehmann[SUP] 2 4 5 [/SUP], Jan Rybniker[SUP] 2 4 5 [/SUP], Philipp Schommers[SUP] 2 4 [/SUP], Dennis A Eichenauer[SUP] 2 6 7 [/SUP], Florian Kurth[SUP] 1 [/SUP], Michael Ramharter[SUP] 1 [/SUP], Rolf Kaiser[SUP] 3 [/SUP], Udo Holtick[SUP] 2 6 [/SUP], Florian Klein[SUP] 3 4 5 [/SUP], Norma Jung[SUP] 2 [/SUP], Veronica Di Cristanziano[SUP] 3 [/SUP]



Affiliations
Free article

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a global health emergency. To improve the understanding of the systemic component of SARS-CoV-2, we investigated if viral load dynamics in plasma and respiratory samples are associated with antibody response and severity of coronavirus disease 2019 (COVID-19). SARS-CoV-2 RNA was found in plasma samples from 14 (44%) out of 32 patients. RNAemia was detected in 5 out of 6 fatal cases. Peak IgG values were significantly lower in mild/moderate than in severe (0.6 (interquartile range, IQR, 0.4-3.2) vs. 11.8 (IQR, 9.9-13.0), adjusted p = 0.003) or critical cases (11.29 (IQR, 8.3-12.0), adjusted p = 0.042). IgG titers were significantly associated with virus Ct (Cycle threshold) value in plasma and respiratory specimens ((? = 0.4, 95% CI (confidence interval, 0.2; 0.5), p < 0.001 and ? = 0.5, 95% CI (0.2; 0.6), p = 0.002). A classification as severe or a critical case was additionally inversely associated with Ct values in plasma in comparison to mild/moderate cases (? = -3.3, 95% CI (-5.8; 0.8), p = 0.024 and ? = -4.4, 95% CI (-7.2; 1.6), p = 0.007, respectively). Based on the present data, our hypothesis is that the early stage of SARS-CoV-2 infection is characterized by a primary RNAemia, as a potential manifestation of a systemic infection. Additionally, the viral load in plasma seems to be associated with a worse disease outcome.

Keywords: SARS-CoV-2; antibodies; blood; dynamics; humoral response; seroconversion; viral load; viremia.
 
Back
Top Bottom